MMED - Leadership updates

NORTHRIDGE, Calif., Sept. 28, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today announced that Sheila Denton has been named General Counsel & Corporate Secretary. "Sheila brings deep board experience, strong regulatory and transactional judgment, and a proven ability to build and lead high-performing global teams," said Que Dallara, Chief Executive Officer of MiniMed. "Her experience advising companies through periods of growth and transformation will make her a strong partner to our executive team and Board as we continue to scale MiniMed as an independent public company.""I'm excited to

David Endicott, Chief Executive Officer of Alcon, brings global healthcare leadership and public company experience; Linnea Burman adds MedTech operating depthNORTHRIDGE, Calif., June 29, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today announced that David Endicott and Linnea Burman have joined its Board of Directors, effective today, expanding the Board from nine to 11 members. Endicott will serve as a member of the Board's Compensation and Talent Committee. David Endicott, Chief Executive Officer of Alcon, brings global healthcare leadership and public company experienceAs MiniMed bui